Celsion Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
500.00
500.00
500.00
500.00
500.00
500
SG&A Expense
15,364.80
23,453.10
20,914.30
20,121.40
18,415.40
21,208.20
EBIT
15,211.50
23,329.90
-
-
18,468.40
21,065
Unusual Expense
7,890.60
967.00
318.90
710.80
1,870.30
889.30
Non Operating Income/Expense
764.20
886.10
1.50
3.50
2.30
0.10
Interest Expense
915.20
1,326.40
1,357.20
723.00
91.80
712
Pretax Income
8,251.40
25,494.30
22,461.10
22,053.70
20,402.20
22,302.50
Consolidated Net Income
8,251.40
25,494.30
22,461.10
22,053.70
20,747.90
11,883.40
Net Income
8,251.40
25,494.30
22,461.10
22,053.70
20,747.90
11,883.40
Net Income After Extraordinaries
8,251.40
25,494.30
22,461.10
22,053.70
20,747.90
11,883.40
Net Income Available to Common
12,852.80
25,494.30
22,461.10
22,053.70
20,747.90
11,883.40
EPS (Basic)
13.29
19.32
14.42
11.90
2.72
0.68
Basic Shares Outstanding
967.20
1,319.50
1,558.10
1,854.10
7,627.20
17,582.90
EPS (Diluted)
13.29
19.32
14.42
11.89
2.72
0.68
Diluted Shares Outstanding
967.20
1,319.50
1,558.10
1,854.10
7,627.20
17,582.90
EBITDA
14,864.80
22,953.10
20,414.30
19,621.40
17,915.40
20,708.20
Non-Operating Interest Income
748.90
1,015.20
63.30
26.40
26.00
363.80
Other After Tax Income (Expense)
-
-
-
-
345.70
-
Preferred Dividends
4,601.40
-
-
-
-
-

About Celsion

View Profile
Address
997 Lenox Drive
Lawrenceville New Jersey 08648
United States
Employees -
Website http://www.celsion.com
Updated 07/08/2019
Celsion Corp . engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies.